pharmaceutical investing AMAG Pharmaceuticals Announces Topline Results From the PROLONG Trial Evaluating Makena
pharmaceutical investing AMAG Pharmaceuticals Acquires Orphan Drug Candidate for Treatment of Severe Preeclampsia
pharmaceutical investing AMAG Pharmaceuticals Submits a New Drug Application to the U.S. Food and Drug Administration
pharmaceutical investing AMAG Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application for Feraheme
pharmaceutical investing AMAG and Endoceutics Enter Into an Exclusive U.S. License Agreement for Intrarosa™ (Prasterone)
pharmaceutical investing AMAG Pharmaceuticals Announces Closing of Exclusive Licensing Agreement for North American Rights to Rekynda™
AMAG Pharmaceuticals Announces Achievement of Key Milestones in Next Generation Development Programs for Makena® and Feraheme®
LaFleur Minerals Acquires Additional Mineral Claims to Expand Its McKenzie East Gold Project in Quebec's Val-d'Or Mining District
Metalsource Mining Intersects 434 g/t AgEq Over 10.64 Metres at Silver Hill, Including 2.1kg/t AgEq, While Continuing to Expand Mineralization Along Strike and at Depth
Fathom Announces Assays from Metasedimentary Hosted Nickel-Copper-Cobalt Mineralization at the Gochager Lake Project
Terra Clean Energy Corp. Files NI 43-101 Technical Report For the Marysvale Uranium Mines Project, Utah
CHARBONE decroche un contrat d'approvisionnement en hydrogene a long terme avec Hone Inc. pour soutenir les solutions energetiques propres pour l'industrie du divertissement